華熙生物(688363.SH):董事、副總經理兼董祕蔣瑞辭職
格隆匯 12 月 24日丨華熙生物(688363.SH)公佈,公司董事會於近日收到公司董事、副總經理兼董事會祕書蔣瑞的書面辭職報告,其因個人原因辭去公司董事、副總經理及董事會祕書職務,辭職後在公司及子公司將不再擔任任何職務。
根據《中華人民共和國公司法》及有關法律法規的規定,蔣瑞的辭職不會導致公司董事會成員人數低於法定最低人數,其關於董事、副總經理、董事會祕書的辭職自其書面辭職報告送達公司董事會時起生效,其離職不會影響公司的正常生產經營活動。
根據《上海證券交易所科創板股票上市規則(2019年4月修訂)》的規定,蔣瑞辭職後,公司指定公司董事長、法定代表人趙燕在董事會祕書空缺期間代行董事會祕書職責,直至公司聘任新任董事會祕書。公司將盡快根據《中華人民共和國公司法》、《上海證券交易所科創板股票上市規則(2019年4月修訂)》、《公司章程》等規定進行董事補選、董事會祕書聘任工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.